天润乳业(600419) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was CNY 618,008,416.08, representing a year-on-year increase of 19.67%[3] - The net profit attributable to shareholders for Q3 2022 was CNY 46,011,375.63, up 45.33% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was CNY 42,005,262.00, an increase of 52.16% year-on-year[3] - The basic earnings per share for Q3 2022 was CNY 0.1437, reflecting a 21.88% increase compared to the same period last year[3] - The net profit for Q3 2022 was CNY 158,135,315.03, an increase of 28.6% compared to CNY 122,825,835.59 in Q3 2021[18] - The total profit for Q3 2022 was CNY 173,268,561.28, an increase of 23.3% from CNY 140,470,791.38 in Q3 2021[18] - The operating profit for Q3 2022 was CNY 181,362,753.24, compared to CNY 142,504,422.52 in Q3 2021, reflecting a growth of 27.2%[18] Revenue and Costs - Total revenue for the first three quarters of 2022 reached CNY 1,851,472,931.78, an increase of 17.7% compared to CNY 1,571,916,458.67 in the same period of 2021[16] - Total operating costs for the first three quarters of 2022 were CNY 1,693,437,215.28, up from CNY 1,443,671,571.47 in 2021, reflecting a year-on-year increase of 17.3%[16] - The company's operating costs for the first three quarters of 2022 were ¥689,755,140.48, slightly higher than ¥672,242,359.07 in the same period of 2021[28] Assets and Liabilities - The total assets at the end of Q3 2022 reached CNY 3,812,293,276.72, a 9.80% increase from the end of the previous year[4] - The total assets as of September 30, 2022, amounted to ¥2,821,425,307.24, a decrease from ¥2,924,663,557.74 at the end of 2021[27] - The total liabilities increased to CNY 1,316,274,844.13 from CNY 1,170,064,759.07, reflecting a rise of 12.5%[14] - The total liabilities decreased to ¥789,923,940.96 from ¥937,452,687.72 in the previous year, indicating improved financial stability[27] - The total equity attributable to shareholders at the end of Q3 2022 was CNY 2,266,333,568.19, a 2.14% increase from the end of the previous year[4] - The total equity increased to ¥2,031,501,366.28 from ¥1,987,210,870.02, reflecting a growth of approximately 2.2%[27] Cash Flow - The net cash flow from operating activities for the year-to-date period decreased by 32.04% due to increased raw material purchases[6] - The cash flow from operating activities for the first nine months of 2022 was CNY 120,865,217.68, down 32.1% from CNY 177,859,685.45 in the same period of 2021[22] - The company's cash inflow from operating activities totaled CNY 2,109,228,722.84 for the first nine months of 2022, compared to CNY 1,831,765,054.22 in the same period of 2021, reflecting a growth of 15.1%[22] - The ending balance of cash and cash equivalents as of the end of the third quarter of 2022 was CNY 458,804,779.55, up from CNY 423,443,472.28 at the end of the same period in 2021[32] Shareholder Information - The company reported a total of 22,213 common shareholders at the end of the reporting period[8] Research and Development - Research and development expenses for the first three quarters of 2022 were CNY 5,336,398.86, compared to CNY 4,645,264.64 in 2021, showing an increase of 14.9%[16]